Narrow Your Results

Strategy

Sections

Keywords

Places

Gray Ratings

Showing 1 - 2 of 2 Results for "stigma"

Results

Provision and Access
Home- and community-based antiretroviral treatment may be effective, but attention must be paid to potential effects of stigma and discrimination. [See also %{c:21}]
Provision and Access
5 studies Gray II, IIIa, IIIb community-based care, home-based care, treatment Rwanda, South Africa, Uganda
Barriers such as cost of medications, stigma, long clinic waits, lack of food, and child-care responsibilities, among others, may discourage women living with HIV from accessing antiretroviral therapy. A study found that patients who were living with HIV but did not access antiretroviral therapy were twice as likely as patients on antiretroviral therapy to report not having enough food to take with treatment as a concern, in addition to concerns about cost barriers. Another study found that cost of ARVs, with direct out of pocket payment at point of care delivery decreased access to ARVs. Another study found transport costs and waiting time a barrier to access to treatment. Increased efforts are needed so that those in pre-ART care understand that HIV can be transmitted prior to ART eligibility.
Provision and Access
1 study